Parvovirus PARV4 visualization and detection

Journal of General Virology

Volumn 91, Issue 2, 2010, Pages 541-544

  Tuke, Philip W ^a,b   Parry, Ruth P ^a   Appleton, Hazel ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b NHS BLOOD AND TRANSPLANT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTROLLED STUDY; HUMAN; NONHUMAN; PARVOVIRUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRAL GENETICS; VIRUS GENOME; VIRUS LOAD; VIRUS PARTICLE; VIRUS TITRATION; BLOOD; ELECTRON MICROSCOPY; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; PARVOVIRUS INFECTION; ULTRASTRUCTURE; VIRION; VIROLOGY;

PARVOVIRIDAE; PARVOVIRUS;

VIRUS ANTIBODY;

ANTIBODIES, VIRAL; HUMANS; MICROSCOPY, ELECTRON; PARVOVIRIDAE INFECTIONS; PARVOVIRUS; VIRAL LOAD; VIRION;

EID: 76249131617     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.014852-0     Document Type: Article

References (17)

1. Anderson, M. J., Jones, S. E., Fisher-Hoch, S. P., Lewis, E., Hall, S. M., Bartlett, C. L., Cohen, B. J., Mortimer, P. P. & Pereira, M. S. (1983). Human parvovirus, the cause of erythema infectiosum (fifth disease)? Lancet 1, 1378.
2. Candotti, D., Parsyan, A., Etiz, N. & Allain, J. P. (2004). Identification and characterisation of persistent human erythrovirus infection in blood donor samples. J Virol 78, 12169-12178.
3. Cossart, Y. E., Field, A. M., Cant, B. & Widdows, D. (1975). Parvovirus-like particles in human sera. Lancet 1, 72-73.
4. Curry, A., Appleton, H. & Dowsett, B. (2006). Application of transmission electron microscopy to the clinical study of viral and bacterial infections: present and future. Micron 37, 91-106.
5. Fryer, J. F., Kapoor, A., Minor, P. D., Delwart, E. & Baylis, S. A. (2006). Novel parvovirus and related variant in human plasma. Emerg Infect Dis 12, 151-154.
6. Fryer, J. F., Delwart, E., Bernardin, F., Tuke, P. W., Lukashov, V. V. & Baylis, S. A. (2007a). Analysis of two human parvovirus PARV4 genotypes identified in human plasma for fractionation. J Gen Virol 88, 2162-2167.
7. Fryer, J. F., Delwart, E., Hecht, F. M., Bernardin, F., Jones, M. S., Shah, N. & Baylis, S. A. (2007b). Frequent detection of the parvoviruses, PARV4 and PARV5, in plasma fromblood donors and symptomatic individuals. Transfusion 47, 1054-1061.
8. Hijikata, M., Abe, K., Win, K. M., Shimizu, Y. K., Keicho, N. & Yoshikura, H. (2001). Identification of new parvovirus DNA sequence in swine sera from Myanmar. Jpn J Infect Dis 54, 244-245.
9. Jones, M. S., Kapoor, A., Lukashov, V. V., Simmonds, P., Hecht, F. & Delwart, E. (2005). New DNA viruses identified in patients with acute viral infection syndrome. J Virol 79, 8230-8236.
10. Lau, S. K.,Woo, P. C., Tse, H., Fu, C. T., Au, W. K., Chen, X. C., Tsoi, H. W., Tsang, T. H., Chan, J. S. & other authors (2008). Identification of novel porcine and bovine parvoviruses closely related to human parvovirus 4. J Gen Virol 89, 1840-1848.
11. Lefrère, J. J., Servant-Delmas, A., Candotti, D., Mariotti, M., Thomas, I., Brossard, Y., Lefre' re, F., Girot, R., Allain, J. P. & Laperche, S. (2005). Persisent B19 infection in immunocompetent individuals: implications for transfusion safety. Blood 106, 2890-2895.
12. Lurcharchaiwong, W., Chieochansin, T., Payungporn, S., Theamboonlers, A. & Poovorawan, Y. (2008). Parvovirus 4 (PARV4) in serum of intravenous drug users and blood donors. Infection 36, 488-491.
13. Manning, A., Willey, S. J., Bell, J. E. & Simmonds, P. (2007). Comparison of tissue distribution, persistence, and molecular epidemiology of parvovirus B19 and novel human parvoviruses PARV4 and human bocavirus. J Infect Dis 195, 1345-1352.
14. Norja, P., Hokynar, K., Aaltonen, L. M., Chen, R., Ranki, A., Partio, E. K., Kiviluoto, O., Davidkin, I., Leivo, T. & other authors (2006). Bioportfolio: lifelong persistence of variant and prototypic erythrovirus DNA genomes in human tissue. Proc Natl Acad Sci U S A 103, 7450-7453.
15. Schneider, B., Fryer, J. F., Oldenburg, J., Brackmann, H. H., Baylis, S. A. & Eis-Hubinger, A. M. (2008). Frequency of contamination of coagulation factor concentrates with novel human parvovirus PARV4. Haemophilia 14, 978-986.
16. Simmonds, P., Manning, A., Kenneil, R., Carnie, F. W. & Bell, J. E. (2007). Parenteral transmission of the novel human parvovirus PARV4. Emerg Infect Dis 13, 1386-1388.
17. Simmonds, P., Douglas, J., Bestetti, G., Longhi, E., Antinori, S., Parravicini, C. & Corbellino, M. (2008). A third genotype of the human parvovirus PARV4 in sub-Saharan Africa. J Gen Virol 89, 2299-2302.